Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
NIKE hosted its 2026 Investor Day to unveil its 'Full Stride Ahead' strategy, focusing on performance sports and sportswear across 23 priority countries. The company established a 2031 financial framework targeting $5 billion in incremental revenue growth and operating margins of 12-14%. Management also committed to returning approximately $12 billion to shareholders through dividends between fiscal 2027 and 2031.
Term
through fiscal 2031
“NIKE is at its best when we start with the athlete and bring the full power of the Company together around sport. Sport has never played a bigger role in people's lives, and as the leader in a growing $330 billion athletic footwear and apparel industry, the opportunity ahead of us has never been greater.”
Elliott Hill, President and Chief Executive Officer of NIKE, Inc.
“We're concentrating our resources where we have the greatest potential to win. We're also changing how we operate — delivering breakthrough products, building deeper local connections and moving faster to capture demand. Together, these actions are designed to return NIKE to sustainable, profitable growth.”
Elliott Hill, President and Chief Executive Officer of NIKE, Inc.
MetaVia announced the completion of the final patient visit in its Phase 1 Part 3A study of DA-1726, a dual GLP-1/glucagon receptor agonist. The company also highlighted interim Part 3B data showing a 68.1% placebo-adjusted reduction in liver fat and 13.5% weight loss, with full data from both parts expected in Q1 2027.
Boxlight Corporation reported Q3 2026 financial results with revenue of $30.1 million and a significant gross margin expansion to 37.1%. The company narrowed its net loss to $1.0 million and improved Adjusted EBITDA to $2.4 million, driven by cost reduction efforts and market share gains for its Clevertouch brand.
Term
Q3 2026
“Our third quarter 2026 results show meaningful improvement across our business. Revenue grew to $30.1 million, gross margin improved to 37.1%, net loss narrowed to $1.0 million from $6.2 million and Adjusted EBITDA increased by $2.8 million to $2.4 million. This improvement is the result of deliberate actions to strengthen gross margin and reduce operating expenses across the company.”
Jennifer Grabow, Interim Chief Financial Officer
“We have also strengthened our balance sheet. We raised $5.5 million of the $7.5 million Series D financing, added a $15 million equity line and reduced our senior secured term loan to $30.0 million. At the same time, Clevertouch gained share to become the No. 4 interactive display brand in North America and No. 5 in EMEA, according to Futuresource Consulting, and our Symphony platform is extending our reach into campus communication and school safety. As schools begin replacing aging classroom displays and other legacy technology, we believe Boxlight is well positioned for growth in 2027 and beyond.”
MAIA Biotechnology reported updated interim efficacy data from Part C of its Phase 2 THIO-101 expansion trial evaluating ateganosine (THIO) in patients with advanced non-small cell lung cancer (NSCLC). The trial demonstrated an 88% disease control rate (DCR) in third-line patients who had progressed after prior immunotherapy and chemotherapy, significantly higher than the 25-35% DCR typically seen with standard chemotherapy.
Aflac Insider Japan Post Holdings Co. Ltd. Sells $2.16M of Stock
Japan Post Holdings Co. Ltd. sold 17,000 shares of Aflac Inc at $127.00 to $127.61 a share (average $127.20) in 2 transactions, worth $2.16M in total on Nov 13, 2026. Shares held after the trade: 50,078,429 (-0.0%).
Nuo Therapeutics reported Q3 2026 financial results with total revenue of $1.9 million, an 80% increase year-over-year. The company highlighted strong growth in hospital-based Aurix sales and noted that final 2027 Medicare reimbursement rulings reinforce its long-term growth outlook.
“As many wound care market participants have commented, the broader wound care space remains unsettled resulting from the dramatic January change to reimbursement economics for skin substitutes/grafts which remained unchanged in the final 2027 rulings mentioned above”
David Jorden, Nuo’s Chief Executive and Financial Officer
“As a business, we are prioritizing both reaching the revenue level required for operational breakeven and assessing opportunities to strengthen our capital structure to support Nuo’s next stage of growth.”
David Jorden, Nuo’s Chief Executive and Financial Officer
Federal Home Loan Bank of Pittsburgh $81M Debt Financing
Federal Home Loan Bank of Pittsburgh committed to issue $81 million in consolidated obligation bonds across six tranches with maturities ranging from 2027 to 2046. These debt securities are joint and several obligations of the eleven Federal Home Loan Banks and are used to fund the bank's operations.
Worthington Enterprises presented at the Baird 2026 Global Industrial Conference in Chicago, providing an overview of its market-leading positions in building, trade, and specialty applications. The company highlighted its long-term financial targets, including a 25% Adjusted EBITDA margin and a 116% free cash flow conversion rate.
Wong Nga Yin Polin resigned as CEO, CFO, Secretary, and Director for personal reasons effective November 14, 2026. Ho Wan Leong was appointed to fill all vacated roles, bringing over 20 years of experience in MedTech, advertising, and capital markets.
ServiceNow delivered a strong Q3 2026 beat, raising AI ACV targets to $1.7 billion while navigating accounting nuances in CRPO and subscription revenue due to strategic deployment investments.
MongoDB, Inc. has acquired Firebolt Analytics Inc. to integrate its high-performance analytics engine into the MongoDB Intelligent Data Platform. The acquisition aims to enable real-time analytics on live operational data without the need for separate data pipelines, supporting applications and AI agents that require sub-second query responses.
Lineage Cell Therapeutics President and CEO Brian M. Culley Buys $37.1K of Stock
Brian M. Culley, President and CEO, bought 40,500 shares of Lineage Cell Therapeutics, Inc. at $0.916 a share, worth $37.1K in total on Nov 16, 2026. Shares held after the trade: 296,016 (+15.9%).
Scotts Miracle-Gro Insider Peter E. Shumlin Sells $240K of Stock
Peter E. Shumlin sold 3,716 shares of Scotts Miracle-Gro Co at $64.51 a share, worth $240K in total on Nov 13, 2026. Shares held after the trade: 27,130 (-12.0%).
Axalta Coating Systems M&A Deal with Akzo Nobel N.V.
Axalta Coating Systems provided a status update on its pending merger of equals with AkzoNobel, specifically furnishing pro forma financial information related to a notes offering by an AkzoNobel subsidiary. The combined company, to be known as MergeCo, will be parented by AkzoNobel, with the merger remaining subject to final regulatory approvals and customary closing conditions.
Service Properties Trust (SVC) filed an investor presentation for the Nareit REITworld conference in November 2026. The presentation outlines SVC's strategic transformation into a pure-play triple net lease REIT and its plan to sell substantially all of its hotel properties by the end of 2028.
Davion Healthcare Insider Julian Sluyters Buys $26.5K of Stock
Julian Sluyters bought 25,000 shares of Davion Healthcare PLC at $1.06 a share, worth $26.5K in total on Nov 16, 2026. Shares held after the trade: 30,000 (+500.0%).
Axe Compute reported Q3 2026 financial results, highlighting a 125% sequential revenue increase to $7.2 million as it transitions to a pure-play GPU-as-a-Service business. The company completed the sale of its Helomics unit and acquired its first owned cluster of 2,304 NVIDIA B300 GPUs for $124.4 million. Axe Compute also reported more than $3 billion in total signed contracts with deployment scaling across the U.S. and Europe.
“The market is still constrained in demand and delivery of GPU capacity, and the companies that win will be the ones that can fund it and deliver with the right value proposition, execution, and financing model. In its second full quarter as a neocloud business, Axe Compute has delivered strong value to its customers and continued executing against its goals.”
Christopher Miglino, Chief Executive Officer of Axe Compute
“We also finished the transformation of the company. Helomics is sold, our first owned cluster is on the books, and Axe Compute is now a pure-play GPU infrastructure company with more than $3 billion in signed contracts. Our first Build cluster is targeted for deployment in the fourth quarter, and the July contracts move into deployment across the United States and Europe in Q4 of 2026 and into 2027. Our job now is delivery.”
Christopher Miglino, Chief Executive Officer of Axe Compute
Nuwellis, Inc. filed an updated corporate investor presentation dated November 17, 2026, to be used for upcoming investor communications and conferences. The presentation highlights the company's Aquadex ultrafiltration technology, its $4.4 billion U.S. market opportunity, and year-to-date revenue growth of 13%.
Generation Income Properties issued a shareholder letter highlighting balance sheet improvements during Q3 2026, including a 73% reduction in redeemable non-controlling interests and a shift from a total equity deficit to a positive $5.7 million equity position. The company also reported receiving $9.1 million in proceeds from property sales during the first nine months of the year and the successful redemption of $20 million in Loci Capital preferred equity.
Air Industries Group M&A Deal with Tenax Aerospace Acquisitions, LLC
Air Industries Group (AIRI) issued a press release disavowing financial illustrations and combined company projections released by its merger partner, Tenax Aerospace Acquisitions, LLC. The company stated that the information was released without its prior review or consent and that stockholders should not rely on the unauthorized pro forma data. The filing serves as a status update on the pending merger, noting that AIRI has not yet verified Tenax's financial results or provided its own 2026 estimates for the illustrations.
Dermata Therapeutics released additional results and photos from its recently completed cosmetic clinical study of Tome Foundational Treatment. The company also announced it has received over 1,000 orders for the skin renewal treatment since its recent commercial launch.
Ainos Wins $9M Contract from ASE Technology Holding Co., Ltd.
Ainos, Inc. signed a $9 million purchase agreement with ASE Technology Holding Co., Ltd. for 5,000 units of its AI NOSE equipment, marking the largest order in the company's history. ASE will pay a 50% deposit ($4.5 million) within 60 days, with the remaining balance due upon delivery completion. The agreement also includes ongoing annual maintenance fees for platform usage and technical updates.
Evolution Metals & Technologies Corp. issued a formal response refuting a short-seller report published by Capybara Research. The company categorically denied allegations of illegal payoffs and involvement with convicted felons, characterizing the report as a 'short and distort' market manipulation tactic.
Perspective Therapeutics Director Frank Morich Buys $14K of Stock
Frank Morich, Director, bought 15,000 shares of Perspective Therapeutics, Inc. at $0.9364 a share, worth $14K in total on Nov 16, 2026. Shares held after the trade: 30,000 (+100.0%).
Sami Totah, Director, sold 2,899 shares of Radcom Ltd at $11.11 a share, worth $32.2K in total on Nov 16, 2026. Shares held after the trade: 21,276 (-12.0%).
Essential Properties Realty Trust released an updated investor presentation and supplemental information package for November 2026. The presentation highlights the company's 99.6% portfolio occupancy, 3.5x unit-level rent coverage, and its ongoing investment activity. Management intends to use the deck for upcoming meetings with institutional investors.
1847 Holdings reported its Q3 2026 financial results, highlighting a 44% year-over-year improvement in operating loss from continuing operations to $0.31 million. The company achieved $1.1 million in positive operating cash flow for the first nine months of 2026 and is actively pursuing the strategic sale of its CMD business to reduce debt.
Term
Q3 2026
“During the first quarter of 2026, the Company’s Board of Directors approved a plan to actively market CMD Inc. and CMD Finish Carpentry LLC (collectively, “CMD”) for sale.”
Lulu's Fashion Lounge Holdings Debt Financing Update with White Oak Commercial Finance, LLC
Lulu’s Fashion Lounge Holdings entered into a third amendment to its 2025 Credit Agreement with White Oak Commercial Finance to increase borrowing flexibility. The amendment permits up to $2.0 million in Overformula Loans, reduces minimum excess availability requirements, and adjusts interest rates and financial covenants through 2027. In exchange for these modifications, the company agreed to pay an amendment fee of up to $0.45 million.
CannaPharmaRx, Inc. reported a net loss of $1,645,647 for the nine months ended September 30, 2026, though it achieved a net income of $645,416 in the third quarter primarily due to non-cash gains from fair value adjustments. The company continues to operate with a significant shareholders' deficit of over $30 million and relies heavily on related party loans to fund its operations.
AXE COMPUTE INC. reported a significant increase in total assets to $686.1 million as of September 30, 2026, driven by substantial investments in property and equipment and compute prepayments. While the company achieved quarterly net income of $11.5 million, it recorded a nine-month net loss of $13.4 million as it transitions its business model and scales operations.